Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare ConferenceGlobeNewsWire • 08/07/24
Compass Therapeutics to Participate in the Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/30/24
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual MeeGlobeNewsWire • 05/23/24
Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceGlobeNewsWire • 05/14/24
Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/13/24
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual ConferenceGlobeNewsWire • 04/12/24
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 04/09/24
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/21/24
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceGlobeNewsWire • 02/29/24
Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 02/08/24
Compass Therapeutics, Inc. (CMPX) Loses -28.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/14/23
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/23
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/03/23
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® IndexesGlobeNewsWire • 06/22/23
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/04/23
Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology DaysGlobeNewsWire • 04/19/23
Compass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology SymposiumGlobeNewsWire • 03/28/23